SCHEMBL21318170

SCHEMBL21318170

Cc1ccccc1NC=NC#N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ GAA P10253 3/20 0.44
▸ LMNA P02545 2/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ TDP1 Q9NUW8 2/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ RECQL P46063 1/20 0.43
▸ HTT P42858 1/20 0.41
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ DHODH Q02127 1/20 0.38
▸ TSHR P16473 2/20 0.38
▸ HPGD P15428 3/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ SIGMAR1 Q99720 3/20 0.36
▸ CYP2C9 P11712 1/20 0.35
▸ GRIN2D O15399 1/20 0.35
▸ GRIN3B O60391 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9530892 0.78 TSHR (0.34) MAPTALDH1A1GAALMNAKDM4E
SCHEMBL9530887 0.78 TSHR (0.34) MAPTALDH1A1GAALMNAKDM4E
SCHEMBL19390292 0.76 MAPT (0.43) MAPTALDH1A1GAALMNAKDM4E
SCHEMBL19538786 0.73 MAPT (0.45) MAPTALDH1A1GAALMNAKDM4E
SCHEMBL3735404 0.73 CYP2C9 (0.61) MAPTALDH1A1GAALMNAKDM4E
SCHEMBL29558213 0.73 CYP2C9 (0.61) MAPTALDH1A1GAALMNAKDM4E
SCHEMBL19390276 0.73 MAPT (0.41) MAPTALDH1A1GAALMNAKDM4E
SCHEMBL3735405 0.73 CYP2C9 (0.61) MAPTALDH1A1GAALMNAKDM4E
SCHEMBL13257963 0.72 NPC1 (0.54) MAPTALDH1A1GAALMNAKDM4E
SCHEMBL3127028 0.70 MAPT (0.50) MAPTALDH1A1GAALMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3252045-B1 CYANOGUANIDINES AND THEIR USE AS ANTIVIRAL AGENTS ABBVIE INC (US) 2019-09-04 — — EP disclosed
Send feedback